BioSpace News Archive

Medical gowns are one of the most important pieces of personal protective equipment in the fight against COVID-19. In order to protect themselves from the coronavirus and other pathogens, frontline healthcare workers need medical gowns along with masks, plastic face shields, booties and other protective equipment

EGF THERAMED HEALTH CORP. (CSE:TMED)(OTC PINK:EVAHF)(FRANKFURT:AUHP) (the “Company”) announces that its joint venture partner, Pharmadelic Labs Corp. (“Pharmadelic Labs”), in which the Company holds a 30% equity interest, has secured additional lab facility space in order to expand its research and development of proprietary processes to help create pharmaceutical grade psilocybin-derived ingredients in a synthetic lab environment.

Tetra Bio-Pharma Inc. (“Tetra” or the “Company”) (TSXV:TBP)(OTCQB:TBPMF), a bio-pharmaceutical company engaged in cannabinoid-derived drug discovery and development, today announces the departure of one of its members of the Board of Directors (the “Board).

Jaguar Health, Inc.'s (NASDAQ:JAGX) chief of sustainability and ethnobotanist Steven King, Ph.D. was featured on Forest Trends’ Viewpoints, discussing the ancient and powerful medicinal knowledge of Indigenous peoples and local communities in the Amazon Rainforest, the importance of understanding, respecting and conserving this vast body of wisdom along with the rainforests, and the pioneering fair-trade tree-to-bottle development of Mytesi

Heat Biologics, Inc. (“Heat”) (NASDAQ:HTBX), a clinical-stage biopharmaceutical company focused on developing first-in-class therapies to modulate the immune system, including multiple oncology product candidates and a novel COVID-19 vaccine, today announced that the first patient has been treated in the Company’s first-in-human Phase 1 clinical trial evaluating PTX-35,

ReShape Lifesciences Inc. (OTCQB:RSLS), a leading developer and distributor of minimally-invasive medical devices to treat obesity and metabolic diseases, today announced a partnership with inHealth Lifestyle Therapeutics (formerly inHealth Medical Services), a Lifestyle Therapeutics company, to launch the ReShapeCare™ virtual health coaching program this month.

Lonza has expanded its cell culture media portfolio with the addition of the GSv9™ Media and Feeds, providing a fully integrated solution specifically designed to optimize recombinant protein production using Lonza’s GS Gene Expression System®. The new chemically defined, animal-component free media and feeds are easy to implement, highly robust and enable greater batch-to-batch consistency.

WUHAN GENERAL GROUP, INC. (OTC PINK:WUHN) (“Wuhan” or the “Company”), a bioceutical company focused on alternative plant-based cannabinoids and psilocybin medical research is pleased to announce a corporate name change and rebranding of the company to M2Bio Sciences, Inc (“M2Bio”).

Agreement to harness TTP’s industry expertise to assess the potential of emerging healthcare technologies and academic research

ARYA Sciences Acquisition Corp. (“ARYA” or “the Company”) (NASDAQ: ARYA), today announced that, due to the public health and safety concerns related to the coronavirus (COVID-19) pandemic and recommendations and orders from federal and New York authorities, the annual general meeting of ARYA shareholders, which will be held on Monday, June 29, 2020 at 9:00 a.m., New York City Time (the “General Meeting”) will be held remotely by teleconference.